Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.
CONCLUSION: Pharmaceutical approach of CVD in T2DM is multilevel and complex. Drug classes featuring pleiotropic effects may boost our armamentarium in the fight against CVD.
PMID: 32013815 [PubMed - in process]
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Patoulias D, Stavropoulos K, Imprialos K, Athyros V, Doumas M, Karagiannis A Tags: Curr Vasc Pharmacol Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Heart Disease | Pandemics | Sodium | Statin Therapy | Study